Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

See all formats and pricing


Select Volume and Issue
Loading journal volume and issue information...

Molecular Detection of Early Appearance of Drug Resistance during Mycobacterium tuberculosis Infection

Thomas C. Victor / Hyeyoung Lee / Sang-Nae Cho / Annemarie M. Jordaan / Gian van der Spuy / Paul D. van Helden / Robin Warren

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 40, Issue 9, Pages 876–881, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2002.155, June 2005

Publication History

Published Online:


During the early development of drug resistance in Mycobacterium tuberculosis (M. tuberculosis) infection only a small proportion of resistant bacteria are present within a milieu of sensitive bacteria. This complicates the use of molecular methods to predict the presence of a resistant phenotype and has been largely ignored in many of the newly developed molecular methods. In this study, mixtures of DNA from M. tuberculosis strains with known wild-type and mutant sequences were used to evaluate the sensitivity of three different molecular methods for detection of drug resistance. The dot-blot and amplification refractory mutation system (ARMS) methods showed sensitivities that approach those of routine phenotypic methods and are able to detect the presence of mutant sequences at a ratio of 1 in 50 (corresponding to 2% mutant sequences). This is 10-fold more sensitive than the commercial kit. The ARMS method was also used to investigate the use of molecular methods to identify mixed infections, and both drug-resistant and susceptible strain populations were identified in a single clinical isolate. These findings highlight the applicability of molecular methods to the rapid detection of drug resistance in tuberculosis patients, particularly in those who are non-compliant and in contacts of known drug-resistant tuberculosis patients, and assistance in limiting the spread of drug-resistant strains.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Igor Mokrousov, N.Vijaya Bhanu, Philip N Suffys, Gururaj V Kadival, Sook-Fan Yap, Sang-Nae Cho, Annemarie M Jordaan, Olga Narvskaya, Urvashi B Singh, Harrison M Gomes, Hyeyoung Lee, Savita P Kulkarni, Kuo-Chieh Lim, Baldip K Khan, Dick van Soolingen, Thomas C Victor, and Leo M Schouls
Journal of Microbiological Methods, 2004, Volume 57, Number 3, Page 323
Sang-Nae Cho and Patrick J. Brennan
Tuberculosis, 2007, Volume 87, Page S14
Paul D van Helden, Peter R Donald, Thomas C Victor, H Simon Schaaf, Eileen G Hoal, Gerhard Walzl, and Robin M Warren
Expert Review of Anti-infective Therapy, 2006, Volume 4, Number 5, Page 759

Comments (0)

Please log in or register to comment.